Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royalmount Pharma is a Canadian specialty pharmaceutical company headquartered in Montreal, Quebec, and operates as a division of Marcan Pharmaceuticals. The company focuses on the acquisition, in-licensing, and commercialization of high-quality pharmaceutical products specifically for the Canadian market. Their diverse portfolio includes complex generics and specialty branded medications, with a particular emphasis on injectable and oral formulations for hospital and retail use. Royalmount Pharma serves several critical therapeutic areas, including oncology, endocrinology, and rheumatology. By leveraging its extensive regulatory expertise and established distribution networks, the company ensures the availability of essential treatments to healthcare providers and patients across Canada. As part of the global Emcure Pharmaceuticals group, Royalmount Pharma benefits from a robust international supply chain and world-class manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royalmount Pharma.